Journal
TURKISH JOURNAL OF MEDICAL SCIENCES
Volume 51, Issue 4, Pages 2177-2184Publisher
Tubitak Scientific & Technological Research Council Turkey
DOI: 10.3906/sag-2008-258
Keywords
Ischemia reperfusion injury; interleukin-1 receptor antagonist; anakinra
Categories
Funding
- Eskisehir Osmangazi University Scientific Research Projects Commission
Ask authors/readers for more resources
The study demonstrated that anakinra has a protective effect on intestinal ischemia-reperfusion injury, inhibiting the expression of inflammatory factors and reducing oxidative stress. A dose of 100 mg/kg was found to be more effective in preserving tissue structure compared to 50 mg/kg.
Background/aim: Even though interleukin-1 receptor antagonist, IL-1Ra, is used in certain inflammatory diseases, its effect on ischemia-reperfusion injury is a current research topic. We aimed to investigate the protective effects of anakinra, an IL-1Ra, on the I/R induced intestinal injury. Materials and methods: The rat model of intestinal ischemia-reperfusion was induced. Rats were randomized into 4 groups: (group 1) control group, (group 2) I/R group, (group 3 and 4) treatment groups (50 mg/kg and 100 mg/kg, respectively). Gene expressions of caspase-3, TNF-alpha, IL-1 alpha, IL-6, and apoptotic cells in tissue samples were evaluated by PCR and TUNEL methods, respectively. Plasma levels of superoxide dismutase (SOD), catalase (CAT), and malondialdehyde (MDA) were studied by the ELISA method and tissue samples were examined histopathologically as well. Results: Anakinra inhibited the expression of IL-1 alpha, IL-6, and TNF-alpha and decreased the SOD, CAT, and MDA caused by ischemiareperfusion injury in both treatment groups. Caspase-3 expression and TUNEL-positive cell number in treatment groups were also less. Histopathologically, anakinra better preserved the villous structure of the small intestine at a dose of 100 mg/kg than 50 mg/kg. Conclusion: Anakinra decreased the intestinal damage caused by ischemia-reperfusion and a dose of 100 mg/kg was found to be histopathologically more effective.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available